Recommended Naloxone Dose for Suspected Opioid Overdose
For adults with suspected opioid overdose and respiratory depression (but not in cardiac arrest), administer an initial dose of 0.4 to 2 mg naloxone intravenously, with the option to start at lower doses (0.04 to 0.4 mg) in opioid-dependent individuals to minimize withdrawal symptoms, repeating or escalating to 2 mg every 2-3 minutes if inadequate response. 1, 2
Initial Dose Selection
Adult Dosing:
- Standard initial dose: 0.4 to 2 mg IV for known or suspected opioid overdose 2
- Lower initial dose: 0.04 to 0.4 mg should be considered in opioid-dependent patients to avoid precipitating severe withdrawal (agitation, hypertension, violent behavior) 1, 3
- If no response after 10 mg total naloxone administered, question the diagnosis of opioid toxicity 2
Pediatric Dosing:
- Initial dose: 0.01 mg/kg IV 2
- If inadequate response, subsequent dose of 0.1 mg/kg may be administered 2
Neonatal Dosing:
- 0.01 mg/kg IV, IM, or subcutaneous 2
Route of Administration Priority
The evidence supports multiple effective routes, with selection based on clinical circumstances:
Intravenous (IV) - Preferred when available:
- Fastest onset of action and allows for precise dose titration 2, 4
- Recommended in emergency situations 2
Intranasal (IN) - Equally effective alternative:
- 2 mg dose, repeated in 3-5 minutes if necessary 3
- Higher-concentration intranasal formulations (2 mg/mL) have similar efficacy to intramuscular naloxone 5
- Slightly longer onset of action compared to IV/IM (mean difference 0.63 standardized units) 6
- May require rescue dosing 2.17 times more often than injectable routes 6
- Reduces needle-stick exposure risk for providers 7
Intramuscular (IM) - When IV unavailable:
- 2 mg dose, repeated in 3-5 minutes if necessary 3
- Slower onset than IV but effective 2
- Disfavored compared to IV due to difficulty with titration and slower clinical effect 4
Repeat Dosing Algorithm
If inadequate response after initial dose:
- Repeat dosing at 2-3 minute intervals 1, 2
- Continue escalating dose up to 2 mg per administration 1
- Some patients may require much higher total doses for atypical opioids (propoxyphene) or massive overdoses 1
- With synthetic opioids like fentanyl, multiple administrations are frequently needed (78% of real-world overdoses required ≥2 doses, 30% required ≥3 doses) 8
Critical Management Priorities
Airway and breathing support takes precedence:
- Provide bag-mask ventilation FIRST before naloxone administration 1, 3
- In cardiac arrest, focus on high-quality CPR; naloxone has no proven benefit and should not delay resuscitation 1
- For respiratory arrest with pulse present, administer naloxone alongside standard BLS/ACLS care 1
Post-Administration Monitoring
Observation requirements:
- Naloxone duration of action is 45-70 minutes (or 30-60 minutes per some sources), often shorter than opioid effects 1
- Patients must be observed in healthcare setting until risk of recurrent toxicity is low and vital signs normalized 1, 3
- Longer observation needed for long-acting opioids (methadone, sustained-release formulations) 1
Managing recurrent toxicity:
- Administer repeated small doses or continuous infusion if respiratory depression recurs 1, 3
- Infusion preparation: 2 mg naloxone in 500 mL normal saline or D5W (concentration 0.004 mg/mL), titrated to patient response 2
Common Pitfalls to Avoid
Withdrawal precipitation:
- Excessive doses cause significant reversal of analgesia, hypertension, nausea, vomiting, sweating, agitation, and circulatory stress 1, 2
- Use lowest effective dose to minimize these effects 3
Premature discharge:
Delayed resuscitation:
- Do not delay standard CPR or airway management while waiting for naloxone effect 3
Misdiagnosis: